Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of Tuesday, October 6, 2026.
RETURN ON EQUITY (ROE)
N/A
Conexeu Sciences Inc.
Market Cap
$97.67M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$96.58M
Return on Equity (ROE)
-11.85%
TTM Avg
-51.56%
3Y Avg
-105.39%
5Y Avg
-105.39%
Market Cap
$97.44M
Return on Equity (ROE)
-103.31%
TTM Avg
-140.03%
3Y Avg
-67.31%
5Y Avg
-49.97%
Market Cap
$98.41M
Return on Equity (ROE)
-34.11%
TTM Avg
-78.33%
3Y Avg
-16.94%
5Y Avg
-8.09%
Market Cap
$97.61M
Return on Equity (ROE)
-584.65%
TTM Avg
-344.54%
3Y Avg
-57.14%
5Y Avg
-65.05%
Market Cap
$94.72M
Return on Equity (ROE)
-461.14%
TTM Avg
-233.39%
3Y Avg
-227.67%
5Y Avg
-163.94%
Market Cap
$100.71M
Return on Equity (ROE)
23.96%
TTM Avg
-4.38%
3Y Avg
-11.56%
5Y Avg
6.84%
Market Cap
$90.38M
Return on Equity (ROE)
-268.09%
TTM Avg
-238.76%
3Y Avg
-155.55%
5Y Avg
-124.74%
Market Cap
$89.80M
Return on Equity (ROE)
N/A
TTM Avg
329.82%
3Y Avg
69.21%
5Y Avg
21.28%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $97.67M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | -11.85% | -51.56% | -105.39% | -105.39% |
| Korro Bio, Inc. (KRRO)vs › | $97.44M | -103.31% | -140.03% | -67.31% | -49.97% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $98.41M | -34.11% | -78.33% | -16.94% | -8.09% |
| PolyPid Ltd. (PYPD)vs › | $97.61M | -584.65% | -344.54% | -57.14% | -65.05% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $94.72M | -461.14% | -233.39% | -227.67% | -163.94% |
| The Joint Corp. (JYNT)vs › | $100.71M | 23.96% | -4.38% | -11.56% | 6.84% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.38M | -268.09% | -238.76% | -155.55% | -124.74% |
| electroCore, Inc. (ECOR)vs › | $89.80M | N/A | 329.82% | 69.21% | 21.28% |
| Equillium, Inc. (EQ)vs › | $90.10M | -32.15% | -60.32% | -93.79% | -79.41% |
ROE
N/A
ROA
N/A
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
